/
/
/

ANG Lifesciences India Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Dec 2020
₹15 Cr₹24 Cr₹19 Cr₹26 Cr₹25 Cr₹17 Cr₹25 Cr₹33 Cr₹18 Cr₹38 Cr₹19 Cr₹33 Cr₹56 Cr₹39 Cr₹47 Cr₹60 Cr₹74 Cr₹95 Cr₹50 Cr₹89 Cr₹120 Cr₹32 Cr
₹11 L₹17 L₹16 L₹12 L₹9 L₹65 L-₹27 L₹35 L₹1 Cr₹19 L-₹3 L₹22 L₹32 L₹9 Cr₹24 L₹16 L₹9 L₹57 L₹16 L₹10 L₹8 L₹4 L
₹15 Cr₹24 Cr₹19 Cr₹26 Cr₹25 Cr₹17 Cr₹24 Cr₹33 Cr₹20 Cr₹38 Cr₹19 Cr₹33 Cr₹57 Cr₹49 Cr₹47 Cr₹60 Cr₹74 Cr₹96 Cr₹50 Cr₹90 Cr₹120 Cr₹32 Cr
₹19 Cr₹23 Cr₹23 Cr₹27 Cr₹25 Cr₹19 Cr₹29 Cr₹32 Cr₹22 Cr₹37 Cr₹22 Cr₹34 Cr₹52 Cr₹53 Cr₹46 Cr₹52 Cr₹64 Cr₹85 Cr₹46 Cr₹71 Cr₹91 Cr₹31 Cr
-₹2 Cr₹3 Cr-₹3 Cr₹20 L₹73 L-₹5 L-₹2 Cr₹3 Cr-₹42 L₹4 Cr-₹2 Cr₹2 Cr₹7 Cr-₹1 Cr₹3 Cr₹10 Cr₹12 Cr₹13 Cr₹5 Cr₹20 Cr₹30 Cr₹2 Cr
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹93 L
-₹6 Cr-₹1 Cr-₹6 Cr-₹3 Cr-₹3 Cr-₹4 Cr-₹6 Cr-₹1 Cr-₹4 Cr-₹4 Cr-₹6 Cr-₹3 Cr₹2 Cr-₹6 Cr-₹3 Cr₹4 Cr₹7 Cr₹7 Cr₹2 Cr₹17 Cr₹28 Cr₹46 L
-₹4 Cr-₹1 Cr-₹5 Cr-₹3 Cr-₹2 Cr-₹2 Cr-₹5 Cr-₹2 Cr-₹3 Cr-₹4 Cr-₹6 Cr-₹2 Cr₹2 Cr-₹5 Cr-₹2 Cr₹3 Cr₹3 Cr₹5 Cr₹1 Cr₹13 Cr₹20 Cr₹22 L

Share Price Live Stats

Open (₹)34.09
Volume (₹)1,365.00
High (₹)34.09
Upper Circuit34.09
Low (₹)33.40
Lower Circuit32.77
Prev Close33.43
52W High (₹)49.69
Price34.09
52W Low (₹)17.63

Share Market Cap & Key Ratios Overview

M.Cap (₹)43.65 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity1.26
Price to Book0.46
Book Value48.99
EPS (TTM)-10.20
Face Value10.00
ROE (%)-17.70

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
ANG-TNSE
LTP
1W Low
1W High
Market cap (₹)
1946.45+16 (0.83%)
1862.80
2088.90
4,56,833Cr
10005+840 (9.17%)
9051.85
10005
2,45,426Cr
5236.85+277.9 (5.60%)
4822.25
5251
1,87,320Cr
1208.25+44.2 (3.80%)
1100
1233.10
1,13,217Cr
1520+102 (7.19%)
1321.20
1523.10
1,12,212Cr
1856.95-3.05 (-0.16%)
1696.20
1988
1,01,155Cr
2241.85+91.85 (4.27%)
2029.95
2322.10
97,626Cr
2403.9+43.9 (1.86%)
2321
2500
96,859Cr
1269.4+98.4 (8.40%)
1154
1269.40
96,406Cr
1735.85+52.85 (3.14%)
1623.05
1789.50
93,614Cr
34.09+1.94 (6.03%)
31.90
34.09
44Cr

Key Highlights of ANG Lifesciences India Ltd’s P&L

In 2025-03-31, ANG Lifesciences India Ltd reported total revenue of ₹95.06Cr, compared with ₹146.81Cr in 2024-03-31, reflecting ANG Lifesciences India Ltd turnover.

Depreciation was ₹6.76Cr and finance costs were ₹9.25Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹-₹15.7Cr in 2025-03-31 as compared to ₹-₹10.71Cr in 2024-03-31.

Net Profit (PAT) was ₹-₹12.41Cr in 2025-03-31 compared with ₹-₹10.14Cr in 2024-03-31.

Earnings per share (EPS) were ₹-9.51 in 2025-03-31, compared with ₹-7.77 in 2024-03-31.